TEDCO Blog

As TEDCO Expands Its Executive Search 

The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.  

Maryland Technology Development Corporation (TEDCO) is once again accepting applications from startups seeking investment from several of its funds that were put on hold in the middle of 2019.

New technology commercialization projects and spin-outs funded

including the pre-seed funds, seed fund and venture fund

   

The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies for the market, TEDCO announced Tuesday.

The NIST Science and Technology Entrepreneurship Program (N-STEP) Commercializes NIST Research 

Project will support the increasing global need for “off-the-shelf” cell banks and hMSC bioprocess media products as sales continue to climb.

Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases

CSL Ventures, Blu Ventures, Texas Ventures and Texas Halo Fund lead investment in Machfu’s technology that securely connects critical assets and sensors to modern web services

'It was a life saver': New London developed device for feeding tube insertions is a world first

Governor Hogan appoints Kathie Callahan Brady and Chung Hei Sing   

TEDCO's 2019 Entrepreneur Expo - Keynote Speakers  Bob Ackerman, FOUNDER AND MANAGING DIRECTOR , ALLEGISCYBER CAPITAL Justin Klein, FOUNDER AND MANAGING PARTNER, VENSANA CAPITAL View Video

TEDCO's 2019 Entrepreneur Expo - Keynote Speaker Dr. Marco A. Chacón, Founder & President of IRAZÚ Bio-Holdings LLC View Video